Bill Text: CT SB00866 | 2017 | General Assembly | Comm Sub

---

Bill Title: An Act Concerning Cannabidiol Prescription Medication.

Spectrum: Committee Bill

Status: (Introduced - Dead) 2017-03-16 - File Number 87 [SB00866 Detail]

Download: Connecticut-2017-SB00866-Comm_Sub.html

---

General Assembly		Raised Bill No. 866
January Session, 2017		LCO No. 4303
		*_____SB00866GL____030817____*
Referred to Committee on GENERAL LAW
Introduced by:
(GL)

AN ACT CONCERNING CANNABIDIOL PRESCRIPTION MEDICATION.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

Section 1. (NEW) (Effective July 1, 2017) If a cannabidiol investigational product is newly approved or rescheduled by the federal Food and Drug Administration, as a prescription medication, as defined in section 17b-499 of the general statutes, such investigational product shall be deemed approved as a prescription medication in this state.

This act shall take effect as follows and shall amend the following sections:
Section 1	July 1, 2017	New section

GL

Joint Favorable